|
C20ORF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.499400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.729200E-01 |
| Normal-vs-Stage2 |
8.499700E-02 |
| Normal-vs-Stage3 |
5.626000E-01 |
| Normal-vs-Stage4 |
2.717800E-02 |
| Stage1-vs-Stage2 |
9.524300E-02 |
| Stage1-vs-Stage3 |
3.376200E-01 |
| Stage1-vs-Stage4 |
4.241800E-03 |
| Stage2-vs-Stage3 |
3.573500E-02 |
| Stage2-vs-Stage4 |
1.840320E-03 |
| Stage3-vs-Stage4 |
9.099700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.717200E-01 |
| Normal-vs-AfricanAmerican |
9.804200E-01 |
| Normal-vs-Asian |
9.664200E-01 |
| Caucasian-vs-AfricanAmerican |
5.871200E-01 |
| Caucasian-vs-Asian |
5.160400E-01 |
| AfricanAmerican-vs-Asian |
9.562200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.769200E-01 |
| Normal-vs-Female |
6.733800E-01 |
| Male-vs-Female |
8.004300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.833200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.889800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.744550E-01 |
| Normal-vs-Age(81-100Yrs) |
7.718800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.649600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.837160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.158200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.707880E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.477400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.632250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.064800E-01 |
| Classical-VS-Follicular |
5.858499999567E-07 |
| Classical-VS-Other |
3.177800E-01 |
| Classical-VS-Normal |
2.819600E-01 |
| Tall-VS-Follicular |
5.03200000001591E-07 |
| Tall-VS-Other |
8.396200E-02 |
| Tall-VS-Normal |
4.286100E-02 |
| Follicular-VS-Other |
3.273400E-01 |
| Follicular-VS-Normal |
2.589500E-04 |
| Other-VS-Normal |
5.423600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.007200E-01 |
| Normal-vs-N1 |
4.952000E-01 |
| N0-vs-N1 |
3.253800E-01 |
|
|
